APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Riboside (NR)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nicotinamide Riboside (NR) Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchNicotinamide Riboside (NR) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Riboside (NR) Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Nicotinamide Riboside (NR) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Riboside (NR) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Riboside (NR) Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Nicotinamide Riboside (NR) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nicotinamide Riboside (NR) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nicotinamide Riboside (NR) market include ChromaDex, Genex Formulas, Bontac, Tiantai Biotechnology, Zhejiang Jiahua, Shandong Tianming Pharmaceutical, Suzhou MyLand Pharm & Nutrition, EnzymeWorks and Longer Livetech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nicotinamide Riboside (NR) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicotinamide Riboside (NR) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicotinamide Riboside (NR) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotinamide Riboside (NR) market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicotinamide Riboside (NR) Segment by Company

ChromaDex

Genex Formulas

Bontac

Tiantai Biotechnology

Zhejiang Jiahua

Shandong Tianming Pharmaceutical

Suzhou MyLand Pharm & Nutrition

EnzymeWorks

Longer Livetech

Shenzhen Ejion Biotechnology

Nicotinamide Riboside (NR) Segment by Type

Purity ≤98%

Purity ＞98%

Nicotinamide Riboside (NR) Segment by Application

Health Supplement

Pharmaceutical Additives

Nicotinamide Riboside (NR) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Nicotinamide Riboside (NR) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nicotinamide Riboside (NR) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nicotinamide Riboside (NR) significant trends, drivers, influence factors in global and regions.

6. To analyze Nicotinamide Riboside (NR) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside (NR) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside (NR).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotinamide Riboside (NR) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Riboside (NR) industry.

Chapter 3: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nicotinamide Riboside (NR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nicotinamide Riboside (NR) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nicotinamide Riboside (NR) Industry Trends Table 2. Nicotinamide Riboside (NR) Industry Drivers Table 3. Nicotinamide Riboside (NR) Industry Opportunities and Challenges Table 4. Nicotinamide Riboside (NR) Industry Restraints Table 5. Global Nicotinamide Riboside (NR) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nicotinamide Riboside (NR) Revenue Share by Company (2021-2026) Table 7. Global Nicotinamide Riboside (NR) Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Nicotinamide Riboside (NR) Sales Volume Share by Company (2021-2026) Table 9. Global Nicotinamide Riboside (NR) Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Nicotinamide Riboside (NR) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nicotinamide Riboside (NR) Key Company Manufacturing Base & Headquarters Table 12. Global Nicotinamide Riboside (NR) Company, Product Type & Application Table 13. Global Nicotinamide Riboside (NR) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicotinamide Riboside (NR) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≤98% Table 18. Significant Companies of Purity ＞98% Table 19. Global Nicotinamide Riboside (NR) Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Nicotinamide Riboside (NR) Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Nicotinamide Riboside (NR) Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Nicotinamide Riboside (NR) Sales Volume Share by Type (2021-2026) Table 23. Global Nicotinamide Riboside (NR) Sales Volume Share by Type (2027-2032) Table 24. Global Nicotinamide Riboside (NR) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nicotinamide Riboside (NR) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nicotinamide Riboside (NR) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nicotinamide Riboside (NR) Sales Value Share by Type (2021-2026) Table 28. Global Nicotinamide Riboside (NR) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Health Supplement Table 30. Significant Companies of Pharmaceutical Additives Table 31. Global Nicotinamide Riboside (NR) Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Nicotinamide Riboside (NR) Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Nicotinamide Riboside (NR) Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Nicotinamide Riboside (NR) Sales Volume Share by Application (2021-2026) Table 35. Global Nicotinamide Riboside (NR) Sales Volume Share by Application (2027-2032) Table 36. Global Nicotinamide Riboside (NR) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Nicotinamide Riboside (NR) Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Nicotinamide Riboside (NR) Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Nicotinamide Riboside (NR) Sales Value Share by Application (2021-2026) Table 40. Global Nicotinamide Riboside (NR) Sales Value Share by Application (2027-2032) Table 41. Global Nicotinamide Riboside (NR) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Nicotinamide Riboside (NR) Sales by Region (2021-2026) & (Tons) Table 43. Global Nicotinamide Riboside (NR) Sales Market Share by Region (2021-2026) Table 44. Global Nicotinamide Riboside (NR) Sales by Region (2027-2032) & (Tons) Table 45. Global Nicotinamide Riboside (NR) Sales Market Share by Region (2027-2032) Table 46. Global Nicotinamide Riboside (NR) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Nicotinamide Riboside (NR) Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Nicotinamide Riboside (NR) Sales Value Share by Region (2021-2026) Table 49. Global Nicotinamide Riboside (NR) Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Nicotinamide Riboside (NR) Sales Value Share by Region (2027-2032) Table 51. Global Nicotinamide Riboside (NR) Market Average Price (US$/Ton) by Region (2021-2026) Table 52. Global Nicotinamide Riboside (NR) Market Average Price (US$/Ton) by Region (2027-2032) Table 53. Global Nicotinamide Riboside (NR) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Nicotinamide Riboside (NR) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 56. Global Nicotinamide Riboside (NR) Sales Market Share by Country (2021-2026) Table 57. Global Nicotinamide Riboside (NR) Sales by Country (2027-2032) & (Tons) Table 58. Global Nicotinamide Riboside (NR) Sales Market Share by Country (2027-2032) Table 59. Global Nicotinamide Riboside (NR) Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Nicotinamide Riboside (NR) Sales Value Market Share by Country (2021-2026) Table 61. Global Nicotinamide Riboside (NR) Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Nicotinamide Riboside (NR) Sales Value Market Share by Country (2027-2032) Table 63. ChromaDex Company Information Table 64. ChromaDex Business Overview Table 65. ChromaDex Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. ChromaDex Nicotinamide Riboside (NR) Product Portfolio Table 67. ChromaDex Recent Development Table 68. Genex Formulas Company Information Table 69. Genex Formulas Business Overview Table 70. Genex Formulas Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Genex Formulas Nicotinamide Riboside (NR) Product Portfolio Table 72. Genex Formulas Recent Development Table 73. Bontac Company Information Table 74. Bontac Business Overview Table 75. Bontac Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Bontac Nicotinamide Riboside (NR) Product Portfolio Table 77. Bontac Recent Development Table 78. Tiantai Biotechnology Company Information Table 79. Tiantai Biotechnology Business Overview Table 80. Tiantai Biotechnology Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio Table 82. Tiantai Biotechnology Recent Development Table 83. Zhejiang Jiahua Company Information Table 84. Zhejiang Jiahua Business Overview Table 85. Zhejiang Jiahua Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio Table 87. Zhejiang Jiahua Recent Development Table 88. Shandong Tianming Pharmaceutical Company Information Table 89. Shandong Tianming Pharmaceutical Business Overview Table 90. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio Table 92. Shandong Tianming Pharmaceutical Recent Development Table 93. Suzhou MyLand Pharm & Nutrition Company Information Table 94. Suzhou MyLand Pharm & Nutrition Business Overview Table 95. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio Table 97. Suzhou MyLand Pharm & Nutrition Recent Development Table 98. EnzymeWorks Company Information Table 99. EnzymeWorks Business Overview Table 100. EnzymeWorks Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio Table 102. EnzymeWorks Recent Development Table 103. Longer Livetech Company Information Table 104. Longer Livetech Business Overview Table 105. Longer Livetech Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Longer Livetech Nicotinamide Riboside (NR) Product Portfolio Table 107. Longer Livetech Recent Development Table 108. Shenzhen Ejion Biotechnology Company Information Table 109. Shenzhen Ejion Biotechnology Business Overview Table 110. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio Table 112. Shenzhen Ejion Biotechnology Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Nicotinamide Riboside (NR) Distributors List Table 116. Nicotinamide Riboside (NR) Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Nicotinamide Riboside (NR) Product Image Figure 2. Global Nicotinamide Riboside (NR) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Riboside (NR) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nicotinamide Riboside (NR) Sales (2021-2032) & (Tons) Figure 5. Global Nicotinamide Riboside (NR) Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Nicotinamide Riboside (NR) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≤98% Image Figure 10. Purity ＞98% Image Figure 11. Global Nicotinamide Riboside (NR) Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Nicotinamide Riboside (NR) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nicotinamide Riboside (NR) Sales Volume Share by Type (2021-2032) Figure 14. Global Nicotinamide Riboside (NR) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nicotinamide Riboside (NR) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nicotinamide Riboside (NR) Sales Value Share by Type (2021-2032) Figure 17. Health Supplement Image Figure 18. Pharmaceutical Additives Image Figure 19. Global Nicotinamide Riboside (NR) Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Nicotinamide Riboside (NR) Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Nicotinamide Riboside (NR) Sales Volume Share by Application (2021-2032) Figure 22. Global Nicotinamide Riboside (NR) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Nicotinamide Riboside (NR) Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Nicotinamide Riboside (NR) Sales Value Share by Application (2021-2032) Figure 25. Global Nicotinamide Riboside (NR) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Nicotinamide Riboside (NR) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Nicotinamide Riboside (NR) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Nicotinamide Riboside (NR) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Nicotinamide Riboside (NR) Sales Value (2021-2032) & (US$ Million) Figure 30. North America Nicotinamide Riboside (NR) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Nicotinamide Riboside (NR) Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Nicotinamide Riboside (NR) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Nicotinamide Riboside (NR) Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Nicotinamide Riboside (NR) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Nicotinamide Riboside (NR) Sales Value (2021-2032) & (US$ Million) Figure 36. South America Nicotinamide Riboside (NR) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Nicotinamide Riboside (NR) Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Nicotinamide Riboside (NR) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Nicotinamide Riboside (NR) Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Nicotinamide Riboside (NR) Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≤98%
  • Purity ＞98%
Applications
  • Health Supplement
  • Pharmaceutical Additives
Companies covered
  • ChromaDex
  • Genex Formulas
  • Bontac
  • Tiantai Biotechnology
  • Zhejiang Jiahua
  • Shandong Tianming Pharmaceutical
  • Suzhou MyLand Pharm & Nutrition
  • EnzymeWorks
  • Longer Livetech
  • Shenzhen Ejion Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinamide Riboside (NR) Sales Value (2021-2032)
  4. 1.2.2 Global Nicotinamide Riboside (NR) Sales Volume (2021-2032)
  5. 1.2.3 Global Nicotinamide Riboside (NR) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nicotinamide Riboside (NR) Market Dynamics
  1. 2.1 Nicotinamide Riboside (NR) Industry Trends
  2. 2.2 Nicotinamide Riboside (NR) Industry Drivers
  3. 2.3 Nicotinamide Riboside (NR) Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Riboside (NR) Industry Restraints
3 Nicotinamide Riboside (NR) Market by Company
  1. 3.1 Global Nicotinamide Riboside (NR) Company Revenue Ranking in 2025
  2. 3.2 Global Nicotinamide Riboside (NR) Revenue by Company (2021-2026)
  3. 3.3 Global Nicotinamide Riboside (NR) Sales Volume by Company (2021-2026)
  4. 3.4 Global Nicotinamide Riboside (NR) Average Price by Company (2021-2026)
  5. 3.5 Global Nicotinamide Riboside (NR) Company Ranking (2024-2026)
  6. 3.6 Global Nicotinamide Riboside (NR) Company Manufacturing Base and Headquarters
  7. 3.7 Global Nicotinamide Riboside (NR) Company Product Type and Application
  8. 3.8 Global Nicotinamide Riboside (NR) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nicotinamide Riboside (NR) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nicotinamide Riboside (NR) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nicotinamide Riboside (NR) Market by Type
  1. 4.1 Nicotinamide Riboside (NR) Type Introduction
  2. 4.1.1 Purity ≤98%
  3. 4.1.2 Purity ＞98%
  4. 4.2 Global Nicotinamide Riboside (NR) Sales Volume by Type
  5. 4.2.1 Global Nicotinamide Riboside (NR) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nicotinamide Riboside (NR) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nicotinamide Riboside (NR) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nicotinamide Riboside (NR) Sales Value by Type
  9. 4.3.1 Global Nicotinamide Riboside (NR) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nicotinamide Riboside (NR) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nicotinamide Riboside (NR) Sales Value Share by Type (2021-2032)
5 Nicotinamide Riboside (NR) Market by Application
  1. 5.1 Nicotinamide Riboside (NR) Application Introduction
  2. 5.1.1 Health Supplement
  3. 5.1.2 Pharmaceutical Additives
  4. 5.2 Global Nicotinamide Riboside (NR) Sales Volume by Application
  5. 5.2.1 Global Nicotinamide Riboside (NR) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nicotinamide Riboside (NR) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Nicotinamide Riboside (NR) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Nicotinamide Riboside (NR) Sales Value by Application
  9. 5.3.1 Global Nicotinamide Riboside (NR) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nicotinamide Riboside (NR) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Nicotinamide Riboside (NR) Sales Value Share by Application (2021-2032)
6 Nicotinamide Riboside (NR) Regional Sales and Value Analysis
  1. 6.1 Global Nicotinamide Riboside (NR) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nicotinamide Riboside (NR) Sales by Region (2021-2032)
  3. 6.2.1 Global Nicotinamide Riboside (NR) Sales by Region: 2021-2026
  4. 6.2.2 Global Nicotinamide Riboside (NR) Sales by Region (2027-2032)
  5. 6.3 Global Nicotinamide Riboside (NR) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nicotinamide Riboside (NR) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nicotinamide Riboside (NR) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nicotinamide Riboside (NR) Sales Value by Region (2027-2032)
  9. 6.5 Global Nicotinamide Riboside (NR) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nicotinamide Riboside (NR) Sales Value (2021-2032)
  12. 6.6.2 North America Nicotinamide Riboside (NR) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nicotinamide Riboside (NR) Sales Value (2021-2032)
  15. 6.7.2 Europe Nicotinamide Riboside (NR) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nicotinamide Riboside (NR) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nicotinamide Riboside (NR) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nicotinamide Riboside (NR) Sales Value (2021-2032)
  21. 6.9.2 South America Nicotinamide Riboside (NR) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nicotinamide Riboside (NR) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nicotinamide Riboside (NR) Sales Value Share by Country, 2025 VS 2032
7 Nicotinamide Riboside (NR) Country-level Sales and Value Analysis
  1. 7.1 Global Nicotinamide Riboside (NR) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nicotinamide Riboside (NR) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nicotinamide Riboside (NR) Sales by Country (2021-2032)
  4. 7.3.1 Global Nicotinamide Riboside (NR) Sales by Country (2021-2026)
  5. 7.3.2 Global Nicotinamide Riboside (NR) Sales by Country (2027-2032)
  6. 7.4 Global Nicotinamide Riboside (NR) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nicotinamide Riboside (NR) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nicotinamide Riboside (NR) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nicotinamide Riboside (NR) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nicotinamide Riboside (NR) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nicotinamide Riboside (NR) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ChromaDex
  2. 8.1.1 ChromaDex Company Information
  3. 8.1.2 ChromaDex Business Overview
  4. 8.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ChromaDex Nicotinamide Riboside (NR) Product Portfolio
  6. 8.1.5 ChromaDex Recent Developments
  7. 8.2 Genex Formulas
  8. 8.2.1 Genex Formulas Company Information
  9. 8.2.2 Genex Formulas Business Overview
  10. 8.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Genex Formulas Nicotinamide Riboside (NR) Product Portfolio
  12. 8.2.5 Genex Formulas Recent Developments
  13. 8.3 Bontac
  14. 8.3.1 Bontac Company Information
  15. 8.3.2 Bontac Business Overview
  16. 8.3.3 Bontac Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bontac Nicotinamide Riboside (NR) Product Portfolio
  18. 8.3.5 Bontac Recent Developments
  19. 8.4 Tiantai Biotechnology
  20. 8.4.1 Tiantai Biotechnology Company Information
  21. 8.4.2 Tiantai Biotechnology Business Overview
  22. 8.4.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio
  24. 8.4.5 Tiantai Biotechnology Recent Developments
  25. 8.5 Zhejiang Jiahua
  26. 8.5.1 Zhejiang Jiahua Company Information
  27. 8.5.2 Zhejiang Jiahua Business Overview
  28. 8.5.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio
  30. 8.5.5 Zhejiang Jiahua Recent Developments
  31. 8.6 Shandong Tianming Pharmaceutical
  32. 8.6.1 Shandong Tianming Pharmaceutical Company Information
  33. 8.6.2 Shandong Tianming Pharmaceutical Business Overview
  34. 8.6.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
  36. 8.6.5 Shandong Tianming Pharmaceutical Recent Developments
  37. 8.7 Suzhou MyLand Pharm & Nutrition
  38. 8.7.1 Suzhou MyLand Pharm & Nutrition Company Information
  39. 8.7.2 Suzhou MyLand Pharm & Nutrition Business Overview
  40. 8.7.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio
  42. 8.7.5 Suzhou MyLand Pharm & Nutrition Recent Developments
  43. 8.8 EnzymeWorks
  44. 8.8.1 EnzymeWorks Company Information
  45. 8.8.2 EnzymeWorks Business Overview
  46. 8.8.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio
  48. 8.8.5 EnzymeWorks Recent Developments
  49. 8.9 Longer Livetech
  50. 8.9.1 Longer Livetech Company Information
  51. 8.9.2 Longer Livetech Business Overview
  52. 8.9.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Longer Livetech Nicotinamide Riboside (NR) Product Portfolio
  54. 8.9.5 Longer Livetech Recent Developments
  55. 8.10 Shenzhen Ejion Biotechnology
  56. 8.10.1 Shenzhen Ejion Biotechnology Company Information
  57. 8.10.2 Shenzhen Ejion Biotechnology Business Overview
  58. 8.10.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio
  60. 8.10.5 Shenzhen Ejion Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicotinamide Riboside (NR) Value Chain Analysis
  2. 9.1.1 Nicotinamide Riboside (NR) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicotinamide Riboside (NR) Sales Mode & Process
  6. 9.2 Nicotinamide Riboside (NR) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicotinamide Riboside (NR) Distributors
  9. 9.2.3 Nicotinamide Riboside (NR) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst